Wall Street mixed as tax hikes, inflation data looms

(For a live blog on the U.S. stock market, click

or type LIVE/ in a news window.)

* Inflation, retail sales data on tap this week

* Biden corporate tax hike in focus

* Moderna, Pfizer drop after report that boosters not widely needed

* Indexes: Dow up 0.39%, S&P 500 off 0.06%, Nasdaq down 0.21%

By Stephen Culp

NEW YORK, Sept 13 (Reuters) - Wall Street stocks wavered on Monday, struggling to regain ground lost in last week's bruising sell-off, but economically sensitive shares rose as investors focused on potential corporate tax hikes and upcoming economic data.

The three major U.S. indexes were mixed, with the bellwether S&P 500 index .SPX essentially flat as it flirts with the prospect of extending its five-day losing streak.

But while the Dow Jones Industrial Average .DJI was green, market leading tech and tech-adjacent shares pulled the Nasdaq Composite Index .IXIC into the red.

Investors favored value stocks .IVX over growth .IGX , with stocks set to benefit most from a resurging economy enjoying the biggest percentage gains.

"We had a good rally in the beginning of the day, but it's faded," said Oliver Pursche, senior vice president at Wealthspire Advisors, in New York.

"September's always bumpy and we saw that last week," Pursche added. "But generally speaking the environment is positive for stocks and probably will be through the end of the year."

Market participants are focused on the likely passage of U.S. President Joe Biden's $3.5 trillion budget package, which is expected to include a proposed corporate tax rate hike to 26.5% from 21%.

Goldman Sachs analysts see the corporate tax rate increasing to 25% and the passage of about half of a proposed increase to tax rates on foreign income, which they estimate would reduce S&P 500 earnings by 5% in 2022.

But Pursche believes the corporate tax increase is likely to be smaller.

"Any tax hikes are going to be challenging to pass and are going to be much milder than what the Democrats want," Pursche said.

The Labor Department is due to release its consumer price index data on Tuesday, which could shed further light on the current inflation wave and whether it is as transitory as the Fed insists.

Other key indicators due this week include retail sales and consumer sentiment, which could illuminate how much the demand boom driven by economic re-engagement has been dampened by the highly contagious COVID-19 Delta variant.

The Dow Jones Industrial Average .DJI rose 135.46 points, or 0.39%, to 34,743.18, the S&P 500 .SPX lost 2.64 points, or 0.06%, at 4,455.94 and the Nasdaq Composite .IXIC dropped 31.55 points, or 0.21%, to 15,083.95.

Of the 11 major sectors in the S&P 500, healthcare .SPXHC suffered the largest percentage loss, while energy .SPNY , buoyed by rising crude prices CLc1 was the biggest gainer.

Shares of vaccine makers Moderna MRNA.O and Pfizer Inc PFE.N sank 6.4% and 2.8%, respectively, after experts said COVID booster shots are not widely needed.

Coinbase Global Inc COIN.O announced plans to raise about $1.5 billion through a debt offering aimed at funding product development and potential acquisitions. The cryptocurrency exchanges shares slid 2.9%.

Salesforce.com Inc CRM.N dipped 1.7% as rival Freshworks Inc's regulatory filing indicated that the business engagement and customer engagement software company is aiming for a nearly $9 billion valuation in it U.S. debut.

Advancing issues outnumbered declining ones on the NYSE by a 1.46-to-1 ratio; on Nasdaq, a 1.07-to-1 ratio favored advancers.

The S&P 500 posted 12 new 52-week highs and one new low; the Nasdaq Composite recorded 44 new highs and 65 new lows.
Reporting by Stephen Culp; Additional reporting by Ambar Warrick in Bengaluru; Editing by Richard Chang

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Usamos cookies para lhe dar a melhor experiência no nosso website. Ler mais ou alterar as configurações de cookies.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.